Annual Operating Expenses
$140.71 M
+$14.12 M+11.15%
31 December 2022
Summary:
Eagle Pharmaceuticals annual total operating expenses is currently $140.71 million, with the most recent change of +$14.12 million (+11.15%) on 31 December 2022. During the last 3 years, it has risen by +$31.33 million (+28.64%). EGRX annual operating expenses is now at all-time high.EGRX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$37.48 M
+$252.00 K+0.68%
30 June 2023
Summary:
Eagle Pharmaceuticals quarterly total operating expenses is currently $37.48 million, with the most recent change of +$252.00 thousand (+0.68%) on 30 June 2023. EGRX quarterly operating expenses is now -22.34% below its all-time high of $48.27 million, reached on 30 June 2022.EGRX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EGRX Operating Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | +28.6% | -10.3% |
5 y5 years | +34.1% | +30.6% |
EGRX Operating Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +28.6% | -22.3% | +55.5% |
5 y | 5 years | at high | +34.1% | -22.3% | +66.4% |
alltime | all time | at high | +853.8% | -22.3% | +4110.7% |
Eagle Pharmaceuticals Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
June 2023 | - | $37.48 M(+0.7%) |
Mar 2023 | - | $37.23 M(+18.7%) |
Dec 2022 | $140.71 M(+11.2%) | $31.37 M(-4.3%) |
Sept 2022 | - | $32.79 M(-32.1%) |
June 2022 | - | $48.27 M(+70.6%) |
Mar 2022 | - | $28.29 M(+17.3%) |
Dec 2021 | $126.60 M(+15.7%) | $24.11 M(-42.3%) |
Sept 2021 | - | $41.77 M(+57.3%) |
June 2021 | - | $26.55 M(-22.3%) |
Mar 2021 | - | $34.17 M(+23.9%) |
Dec 2020 | $109.38 M(-3.4%) | $27.58 M(+22.5%) |
Sept 2020 | - | $22.52 M(-10.2%) |
June 2020 | - | $25.09 M(-26.6%) |
Mar 2020 | - | $34.18 M(+1.2%) |
Dec 2019 | $113.18 M(+7.9%) | $33.77 M(+17.6%) |
Sept 2019 | - | $28.71 M(+9.6%) |
June 2019 | - | $26.18 M(+6.8%) |
Mar 2019 | - | $24.52 M(+14.9%) |
Dec 2018 | $104.93 M(+0.9%) | $21.34 M(+7.5%) |
Sept 2018 | - | $19.85 M(-36.5%) |
June 2018 | - | $31.25 M(-3.9%) |
Mar 2018 | - | $32.51 M(+42.9%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2017 | $104.02 M(+27.5%) | $22.76 M(-11.2%) |
Sept 2017 | - | $25.62 M(-14.5%) |
June 2017 | - | $29.96 M(+14.8%) |
Mar 2017 | - | $26.10 M(-22.6%) |
Dec 2016 | $81.62 M(+70.0%) | $33.71 M(+126.7%) |
Sept 2016 | - | $14.87 M(-5.8%) |
June 2016 | - | $15.79 M(-10.5%) |
Mar 2016 | - | $17.65 M(+22.6%) |
Dec 2015 | $48.02 M(+83.7%) | $14.39 M(+16.3%) |
Sept 2015 | - | $12.37 M(+12.6%) |
June 2015 | - | $10.99 M(+7.0%) |
Mar 2015 | - | $10.27 M(+33.8%) |
Dec 2014 | - | $7.68 M(-21.2%) |
Sept 2014 | $26.14 M(+77.2%) | $9.74 M(+35.0%) |
June 2014 | - | $7.22 M(+37.5%) |
Mar 2014 | - | $5.25 M(+33.4%) |
Dec 2013 | - | $3.93 M(-7.2%) |
Sept 2013 | $14.75 M(-23.2%) | $4.24 M(+376.3%) |
June 2013 | - | $890.20 K(-83.7%) |
Mar 2013 | - | $5.47 M(+31.9%) |
Dec 2012 | - | $4.15 M |
Sept 2012 | $19.20 M | - |
FAQ
- What is Eagle Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Eagle Pharmaceuticals?
What is Eagle Pharmaceuticals annual total operating expenses?
The current annual operating expenses of EGRX is $140.71 M
What is the all time high annual operating expenses for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high annual total operating expenses is $140.71 M
What is Eagle Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of EGRX is $37.48 M
What is the all time high quarterly operating expenses for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high quarterly total operating expenses is $48.27 M